Susquehanna Fundamental Investments, LLC Equillium, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.11 - $7.64 $164,700 - $246,244	-32,231 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.03 - $10.5 $136,212 - $284,340	-27,080 Reduced 45.66%	32,231 $230,000
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $41,064 - $77,644	11,800 Added 24.84%	59,311 $317,000
Q3 2020 Nov 16, 2020	BUY	$2.78 - $26.5 $132,080 - $1.26 Million	47,511 New	47,511 $274,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.